| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/12/2002 | WO2002027015A3 Assays for identifying receptors having alterations in signaling |
| 09/12/2002 | WO2002022680A3 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 09/12/2002 | WO2002018605A3 Anti-microbial agents |
| 09/12/2002 | WO2002016613A3 PEAR GENES CODIFYING FOR β-GALACTOSIDASE, PECTIN METHYLESTERASE, POLYGALACTURONASE, EXPANSINS AND THEIR USE |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2002012465A3 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 09/12/2002 | WO2002012462A3 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 09/12/2002 | WO2002012346A3 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 09/12/2002 | WO2001098501A3 Hypersensitive response eliciting domains of bacterial harpins and use thereof |
| 09/12/2002 | WO2001092543A3 Improved methods of transfection |
| 09/12/2002 | WO2001084921A3 Transgenic animal |
| 09/12/2002 | WO2001083529A3 Immunoadhesin for the prevention of rhinovirus infection |
| 09/12/2002 | WO2001081626A3 Methods for clinical diagnosis |
| 09/12/2002 | WO2001081569A3 Heparanase ii, a human heparanase paralog |
| 09/12/2002 | WO2001077354A3 Cell cycle stress-related proteins and methods of use in plants |
| 09/12/2002 | WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses |
| 09/12/2002 | WO2001077151A3 Fdrg proteins and nucleic acid molecules and uses therefor |
| 09/12/2002 | WO2001073118A3 Hybridisation beacon and method of rapid sequence detection and discrimination |
| 09/12/2002 | WO2001071346A3 Binding compounds for cc chemokine receptor 5 and methods for identifying them |
| 09/12/2002 | WO2001069509A3 Clustering method |
| 09/12/2002 | WO2001068078A3 Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection |
| 09/12/2002 | WO2001066744A3 Human transporter proteins and polynucleotides encoding the same |
| 09/12/2002 | WO2001049721A3 Bacterial genes and proteins that are essential for cell viability and their uses |
| 09/12/2002 | WO2001046686A9 Chromatography material and a method using same |
| 09/12/2002 | WO2001046384A3 A method for isolating and purifying multipotential neural progenitor cells and multipotential neural progenitor cells |
| 09/12/2002 | WO2001042467A3 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 09/12/2002 | WO2001040519A3 Methods for identifying modulators for balance related disorders |
| 09/12/2002 | WO2001038509A9 Method for the mutagenesis of nucleotide sequences from plants algae or fungi |
| 09/12/2002 | WO2001036626A9 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 09/12/2002 | WO2001035102A3 Diagnosis and treatment of malignant neoplasms |
| 09/12/2002 | WO2001030848A3 Nucleic acids of the human abc1 gene and applications thereof |
| 09/12/2002 | WO2001020034A3 Methods and compositions for the screening of cell cycle modulators |
| 09/12/2002 | WO2001018175A9 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 09/12/2002 | WO2001016372A9 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 09/12/2002 | WO2001010203A3 Non-human transgenic animals for the study of neurodegenerative syndromes |
| 09/12/2002 | WO2001009386A3 Digital amplification |
| 09/12/2002 | WO2001009192A9 Human monoclonal antibodies to prostate specific membrane antigen |
| 09/12/2002 | WO2001004360A9 Retroviral recombination assays and uses thereof |
| 09/12/2002 | WO2001004322A9 Nucleotide sequences which code for the opca gene |
| 09/12/2002 | WO2001004266A9 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof |
| 09/12/2002 | WO2001002609A3 Method of identifying toxic agents using differential gene expression |
| 09/12/2002 | WO2000077236A3 Methods for enhancing the production of cytokines in cell cultur e |
| 09/12/2002 | WO2000077182A9 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | WO2000069901A3 Proteins with insulin-like activity useful in the treatment of diabetes |
| 09/12/2002 | WO2000068432A3 Diagnosis of primary congenital glaucoma |
| 09/12/2002 | WO2000067792A9 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 09/12/2002 | WO2000066727A9 Tumour-associated antigen |
| 09/12/2002 | WO2000063435A3 Method of identifying toxic agents using differential gene expression |
| 09/12/2002 | WO2000058509A3 Prostate cancer associated human fibronectin gene and biallelic markers |
| 09/12/2002 | WO2000053616A3 Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage |
| 09/12/2002 | US20020129407 Nucleotide sequences coding cell cycle polypeptide for use in detection of modulators fertility in plants |
| 09/12/2002 | US20020129405 Particle-mediated conifer transformation |
| 09/12/2002 | US20020129404 CTR1 homologue from melon |
| 09/12/2002 | US20020129403 Selective control of lignin biosynthesis in transgenic plants |
| 09/12/2002 | US20020129401 Nucleotide sequences coding enzymatic protein for use in textile and wood treatment |
| 09/12/2002 | US20020129400 Nucleotide sequences for use in generation of disease and insect resistant plants |
| 09/12/2002 | US20020129399 Biotin-binding compounds for induction of sterility in plants |
| 09/12/2002 | US20020129398 Transfection, storage and transfer of male germ cells for generation of trangenic species |
| 09/12/2002 | US20020129397 Transgenic mice containing brain-specific membrane-anchored protein gene disruptions |
| 09/12/2002 | US20020129396 Transgenic mice containing CX2 gene disruptions |
| 09/12/2002 | US20020129395 Compositions to identify swine genetically resistant to F18 E. coli associated diseases |
| 09/12/2002 | US20020129394 Method for producing cloned bovines from cells of a bovine intramuscular preadipocyte cell line |
| 09/12/2002 | US20020129393 Expression vector for use in generating genetically engineering animal for use as tool in generating preferential proteins |
| 09/12/2002 | US20020129391 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/12/2002 | US20020129389 Method for determining the in vivo function of DNA coding sequences |
| 09/12/2002 | US20020129388 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis |
| 09/12/2002 | US20020129387 Mammals' milk containing recombinant protein for use in human therapeutics |
| 09/12/2002 | US20020129386 High estrogen-sensitive medaka fish |
| 09/12/2002 | US20020129385 Medthods for improving long-term memory storage and retrieval |
| 09/12/2002 | US20020128781 Statistical combining of cell expression profiles |
| 09/12/2002 | US20020128465 Charge tags and the separation of nucleic acid molecules |
| 09/12/2002 | US20020128464 Nucleotide sequences coding enzymatic polypeptide for use in generating geetically engineered herbicide sensitive plants |
| 09/12/2002 | US20020128463 Polypeptide for use in the treatment and diagnosis of cancer and defects associated with fungal and parasitic infections |
| 09/12/2002 | US20020128462 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of kidney, digestive, fertility, blood pressure and body weight defects |
| 09/12/2002 | US20020128461 Orphan receptor |
| 09/12/2002 | US20020128460 Method for generating hypermutable plants |
| 09/12/2002 | US20020128459 Physiologically active protein originating in mammals |
| 09/12/2002 | US20020128458 Can be used in therapeutic, diagnostic, and pharmacogenomic applications |
| 09/12/2002 | US20020128457 Nucleotide sequences coding enzymatic polypeptides for use in generation of pyrimidine nucleic acids |
| 09/12/2002 | US20020128454 CACNGLIKE3 polypeptides |
| 09/12/2002 | US20020128451 Phthalamide-lanthanide complexes for use as luminescent markers |
| 09/12/2002 | US20020128450 Amino acid sequence for use in the prevention and treatment of asthma, graft-versus-host disease, rheumatoid arthritis and sepsis |
| 09/12/2002 | US20020128449 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |
| 09/12/2002 | US20020128446 Polypeptide for use in the treatment of cell proliferation and differtiation disorders |
| 09/12/2002 | US20020128444 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response |
| 09/12/2002 | US20020128443 Polynucleotides encoding thrombin receptor homologs |
| 09/12/2002 | US20020128442 Human proteins STAM2a and STAM2b, and cDNAs encoding these molecules |
| 09/12/2002 | US20020128438 Expression vector coding preferential protein for use in treatment of cancer; for use in gene therapy |
| 09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
| 09/12/2002 | US20020128436 Therapeutic composition for use in the treatment of autoimune and rheumatic diseases |
| 09/12/2002 | US20020128435 Polypeptide for use in treatment of bone and cell proliferation disorders |
| 09/12/2002 | US20020128433 Isolated protein for use as tool in the detection of tastants, olfactants and attractants |
| 09/12/2002 | US20020128250 Modulating the expression of a gene |
| 09/12/2002 | US20020128220 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 09/12/2002 | US20020128217 Therapeutic use of cis-element decoys in vivo |
| 09/12/2002 | US20020128216 Antisense oligonucleotides and peptide nucleic acids for treating asthma or an eosinophilic syndrome |
| 09/12/2002 | US20020128201 Tumor antigen |
| 09/12/2002 | US20020128200 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals |
| 09/12/2002 | US20020128197 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs |